Amazon’s Globalstar Bet: Inside the Satellite Race
Amazon is in advanced talks to acquire Globalstar, a move that could reshape the satellite internet race against SpaceX Starlink and trigger a new wave of space sector M&A.
Stock Market
Stock market news and analysis, with explanations of company developments, earnings and the forces moving share prices. Start with Market Education if you are new to investing. Find your way around ECMSource.
ASML Q1 2026 Earnings: The AI Chip Supply Chain Signal
ASML reports Q1 2026 earnings this week. As the sole maker of EUV machines, its order book is the best indicator of where the AI chip supercycle is headed.
Microsoft Q3 FY2026 Earnings Preview: Azure and AI in the Spotlight
Microsoft reports Q3 FY2026 earnings on April 29. Here’s what analysts expect from Azure cloud growth, AI Copilot revenue, and the company’s evolving competitive position.
CoreWeave: How the GPU Cloud IPO Became Wall Street’s AI Darling
CoreWeave has surged 176% since its 2025 IPO. Here’s what the GPU cloud provider’s rise reveals about the next phase of AI infrastructure investment.
Blackstone Surges 6%: What Private Equity’s Rally Signals
Blackstone surged 6% on April 13 as private equity benefits from M&A revival, real asset demand, and surging institutional inflows to alternatives.
SanDisk Soars 12% on Nasdaq-100 Entry: The Index Effect Explained
SanDisk surged 11.83% on Nasdaq-100 inclusion news. Here’s the capital markets mechanics behind why index additions reliably move stock prices.
Why BlackRock Just Turned Bullish on U.S. Equities Again
BlackRock’s Investment Institute moved back to overweight U.S. stocks. Here’s the thesis behind the world’s largest asset manager’s bullish reversal.
Nokia’s 60% Rally: The AI Infrastructure Comeback Story
Nokia stock has surged over 60% in 2026, fueled by a Bank of America upgrade and rising demand for AI data center networking. Here’s what’s driving the comeback.
Revolution Medicines Soars 39% on Pancreatic Cancer Breakthrough
Revolution Medicines’ daraxonrasib nearly doubled survival in a Phase 3 pancreatic cancer trial, sending shares up 39% and reigniting biotech M&A speculation.
Oracle’s AI Cloud Bet Is Paying Off: What the ORCL Surge Signals
Oracle stock surged 11% as AI cloud contracts and the Stargate JV accelerate. Here’s what the ORCL rally signals for the cloud wars and enterprise tech.